• LAST PRICE
    1.7200
  • TODAY'S CHANGE (%)
    Trending Down-0.0300 (-1.7143%)
  • Bid / Lots
    1.5200/ 1
  • Ask / Lots
    1.8500/ 10
  • Open / Previous Close
    1.7400 / 1.7500
  • Day Range
    Low 1.7000
    High 1.7500
  • 52 Week Range
    Low 1.2900
    High 2.2700
  • Volume
    52,463
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 1.75
TimeVolumeRFL
09:32 ET1671.74
10:03 ET3551.74
11:11 ET1001.7
12:03 ET24001.7207
12:30 ET4501.72
12:57 ET23331.75
01:14 ET1001.72
01:24 ET2001.72
02:42 ET2571.7
03:23 ET10411.73
03:32 ET2001.7
03:48 ET1001.71
03:52 ET1001.72
03:59 ET357201.72
Data delayed at least 15 minutes.

Industry Peers

Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesRFL
Rafael Holdings Inc
43.2M
-1.4x
---
United StatesPDNLB
Presidential Realty Corp
14.2K
0.0x
---
United StatesPTTTS
Palmetto Real Estate Trust
13.3M
27.6x
+3.53%
United StatesPW
Power REIT
3.5M
-0.1x
---
United StatesMDRR
Medalist Diversified Reit Inc
13.7M
-8.5x
---
United StatesPRLEQ
Pillarstone Capital REIT
9.9K
0.0x
---
As of 2024-09-20

Company Information

Rafael Holdings, Inc. is a holding company with interests in clinical and early-stage pharmaceutical companies. Its segments include Healthcare, Infusion Technology and Real Estate. The Healthcare segment holds interest in LipoMedix Pharmaceuticals Ltd. (LipoMedix), Barer Institute Inc. (Barer), Cornerstone Pharmaceuticals, Inc. (Cornerstone) and Rafael Medical Devices, LLC. The Real Estate segment consists of the Company’s real estate holdings, which is comprised of a portion of a commercial building in Israel. The Infusion Technology segment holds interest in Day Three Labs, Inc. LipoMedix is a clinical-stage pharmaceutical company. Rafael Medical Devices, LLC, an orthopedic-focused medical device company. Cornerstone Pharmaceuticals, Inc. is a cancer metabolism-based therapeutics company. Cyclo Therapeutics Inc. develops Trappsol Cyclo, which is being evaluated in clinical trials for the treatment of Niemann-Pick Disease Type C1 (NPC).

Contact Information

Headquarters
520 Broad StNEWARK, NJ, United States 07120
Phone
212-658-1450
Fax
302-636-5454

Executives

Executive Chairman of the Board
Howard Jonas
President, Chief Executive Officer
William Conkling
Chief Financial Officer
David Polinsky
Chief Medical Officer
John Goldberg
Lead Independent Director
Stephen Greenberg

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
---
Revenue (TTM)
---
Shares Outstanding
---
Rafael Holdings Inc does not pay a dividend.
Beta
---
EPS
---
Book Value
---
P/E Ratio
-1.4x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.